Compare, Analyse Cadila Healthcare with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs MYLAN (US) - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   MYLAN
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
MYLAN
Dec-18
CADILA HEALTHCARE/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3523,474-   
Low Rs2071,912-   
Sales per share (Unadj.) Rs139.21,598.5-  
Earnings per share (Unadj.) Rs11.843.4-  
Cash flow per share (Unadj.) Rs18.6342.7-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs101.41,729.3-  
Shares outstanding (eoy) m1,023.74514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.01.7 119.1%   
Avg P/E ratio x23.762.0 38.3%  
P/CF ratio (eoy) x15.07.9 191.5%  
Price / Book Value ratio x2.81.6 177.0%  
Dividend payout %29.80-   
Avg Mkt Cap Rs m286,0331,385,529 20.6%   
No. of employees `00013.435.0 38.3%   
Total wages/salary Rs m24,1450-   
Avg. sales/employee Rs Th10,632.723,497.5 45.3%   
Avg. wages/employee Rs Th1,801.20-   
Avg. net profit/employee Rs Th898.5638.1 140.8%   
INCOME DATA
Net Sales Rs m142,531822,412 17.3%  
Other income Rs m1,1390-   
Total revenues Rs m143,670822,412 17.5%   
Gross profit Rs m24,198212,810 11.4%  
Depreciation Rs m6,965153,988 4.5%   
Interest Rs m3,41839,555 8.6%   
Profit before tax Rs m14,95419,267 77.6%   
Minority Interest Rs m2880-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,198-3,065 -104.3%   
Profit after tax Rs m12,04422,332 53.9%  
Gross profit margin %17.025.9 65.6%  
Effective tax rate %21.4-15.9 -134.4%   
Net profit margin %8.52.7 311.2%  
BALANCE SHEET DATA
Current assets Rs m87,154459,234 19.0%   
Current liabilities Rs m82,694334,832 24.7%   
Net working cap to sales %3.115.1 20.7%  
Current ratio x1.11.4 76.8%  
Inventory Days Days7184 85.5%  
Debtors Days Days9493 100.5%  
Net fixed assets Rs m133,236159,534 83.5%   
Share capital Rs m1,024438 233.9%   
"Free" reserves Rs m102,7330-   
Net worth Rs m103,757889,699 11.7%   
Long term debt Rs m32,146960,271 3.3%   
Total assets Rs m236,8662,386,519 9.9%  
Interest coverage x5.41.5 361.5%   
Debt to equity ratio x0.31.1 28.7%  
Sales to assets ratio x0.60.3 174.6%   
Return on assets %6.52.6 251.7%  
Return on equity %11.62.5 462.5%  
Return on capital %13.73.2 431.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m38,2480-   
CASH FLOW
From Operations Rs m25,054170,897 14.7%  
From Investments Rs m-10,123-88,335 11.5%  
From Financial Activity Rs m-10,942-79,614 13.7%  
Net Cashflow Rs m3,9891,416 281.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 72.98 Rs / USD

Compare CADILA HEALTHCARE With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: ALEMBIC PHARMA  UNICHEM LAB  STRIDES PHARMA SCIENCE  AJANTA PHARMA  DISHMAN PHARMA  



Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Related Views On News

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks (Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond (Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell (Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond (Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CADILA HEALTHCARE SHARE PRICE


Jan 25, 2021 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

FEATURED VIDEOS

Smallcap Revival: Should You Wait, Keep Holding, or Buy Now?

Crucial Week Ahead for the Indian Stock Market

Great vs Good: Which Stock Will Win in 2021?

Safest Assets in 2021 are Not What You Think...

More Featured Videos

MARKET STATS